Prelude Capital Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Prelude Capital Management’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-223,997	Closed	-$4.68M	–	1930
2022 Q3	$4.68M	Buy	223,997 +43,868	+24%	+$913K	0.17%	91
2022 Q2	$3.74M	Buy	+180,129	New	+$3.21M	0.11%	151
2022 Q1	–	Sell	-23,394	Closed	-$467K	–	2472
2021 Q4	$467K	Buy	+23,394	New	+$440K	0.01%	1056
2020 Q4	–	Sell	-4,568	Closed	-$111K	–	2192
2020 Q3	$111K	Buy	4,568 +847	+23%	+$18.3K	0.01%	872
2020 Q2	$67K	Buy	+3,721	New	+$48.9K	﹤0.01%	1078
2020 Q1	–	Sell	-344	Closed	-$5K	–	2204
2019 Q4	$5K	Buy	+344	New	+$4.17K	﹤0.01%	1784

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prelude Capital Management's CVET Position: Q4 2022 in Review

Prelude Capital Management sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 223,997 shares — an estimated $4.68M sold.

Prelude Capital Management first reported a position in CVET in Q4 2019 and held it in 6 quarters. The position peaked at $4.68M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Prelude Capital Management reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Prelude Capital Management sold 223,997 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $4.68M.
Prelude Capital Management first reported a position in Covetrus, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
Prelude Capital Management's Covetrus, Inc. Common Stock position peaked at $4.68M in Q3 2022.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.